ER+/PR±/HER2- breast cancer Cancer
Conditions
Interventions
Overweight patients with ER+/PR±/HER2- luminal A and B breast cancer, currently under antiestrogenic treatment after surgery and chemotherapy - without diabetes, thyroid or renal disease, eating disor
Sponsors
Carol Davila Medicine University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Overweight patients with ER+/PR±/HER2- luminal A and B breast cancer 2. Currently under antiestrogenic treatment after surgery and chemotherapy
Exclusion criteria
Exclusion criteria: 1. Diabetes 2. Thyroid or renal disease 3. Eating disorders 4. Depression 5. Osteoporosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total body weight, body and and visceral fat using a multi-frequency bioelectrical impedance scale at 6 months and 12 months | — |
Countries
Romania
Outcome results
None listed